Adherence to Statins Use and Risk of Dementia among Patients with Diabetes and Comorbid Hyperlipidemia
The results from previous observational studies and clinical trials about the neuroprotective benefits of statins use for the prevention of dementia are contradictory. It is unclear whether the neuroprotective benefits are experienced in a specific group with a higher risk of dementia, such as patie...
Main Authors: | Ching-Yuan Chang MS, Fang-Ju Lin PhD, Jin-Liern Hong PhD, Chung-Hsuen Wu PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Inquiry: The Journal of Health Care Organization, Provision, and Financing |
Online Access: | https://doi.org/10.1177/00469580211019201 |
Similar Items
-
Statin Medication Adherence and Associated Outcomes in Type 2 Diabetes Medicaid Enrollees with Comorbid Hyperlipidemia
by: Wu, Jun
Published: (2010) -
A Review on Promising Natural Agents Effective on Hyperlipidemia
by: Mahmoud Bahmani PhD, et al.
Published: (2015-07-01) -
A Mechanism for Statin-Induced Susceptibility to Myopathy
by: Sabine Lotteau, PhD, et al.
Published: (2019-08-01) -
How Is the Sexual Function of Premenopausal Chinese Women Without Hyperlipidemia?
by: Yali Xiang, MD, PhD, et al.
Published: (2020-03-01) -
The Comorbid Influence of High Depressive Symptoms and Diabetes on Mortality and Disability in Mexican Americans Aged 75 and Above
by: Brian Downer PhD, et al.
Published: (2016-02-01)